Previous intravitreal injection as a risk factor of posterior capsule rupture in cataract surgery: a systematic review and meta-analysis

Research output: Contribution to journalReviewResearchpeer-review

Standard

Previous intravitreal injection as a risk factor of posterior capsule rupture in cataract surgery : a systematic review and meta-analysis. / Bjerager, Jakob; van Dijk, Elon H.C.; Holm, Lars Morten; Singh, Amardeep; Subhi, Yousif.

In: Acta Ophthalmologica, Vol. 100, No. 6, 2022, p. 614-623.

Research output: Contribution to journalReviewResearchpeer-review

Harvard

Bjerager, J, van Dijk, EHC, Holm, LM, Singh, A & Subhi, Y 2022, 'Previous intravitreal injection as a risk factor of posterior capsule rupture in cataract surgery: a systematic review and meta-analysis', Acta Ophthalmologica, vol. 100, no. 6, pp. 614-623. https://doi.org/10.1111/aos.15089

APA

Bjerager, J., van Dijk, E. H. C., Holm, L. M., Singh, A., & Subhi, Y. (2022). Previous intravitreal injection as a risk factor of posterior capsule rupture in cataract surgery: a systematic review and meta-analysis. Acta Ophthalmologica, 100(6), 614-623. https://doi.org/10.1111/aos.15089

Vancouver

Bjerager J, van Dijk EHC, Holm LM, Singh A, Subhi Y. Previous intravitreal injection as a risk factor of posterior capsule rupture in cataract surgery: a systematic review and meta-analysis. Acta Ophthalmologica. 2022;100(6): 614-623. https://doi.org/10.1111/aos.15089

Author

Bjerager, Jakob ; van Dijk, Elon H.C. ; Holm, Lars Morten ; Singh, Amardeep ; Subhi, Yousif. / Previous intravitreal injection as a risk factor of posterior capsule rupture in cataract surgery : a systematic review and meta-analysis. In: Acta Ophthalmologica. 2022 ; Vol. 100, No. 6. pp. 614-623.

Bibtex

@article{d4a18a1368fe4116b23085465344533c,
title = "Previous intravitreal injection as a risk factor of posterior capsule rupture in cataract surgery: a systematic review and meta-analysis",
abstract = "Purpose: Intravitreal injections and cataract surgery are two common procedures in the elderly. Posterior capsular rupture (PCR) is a rare but important complication of cataract surgery. We systematically reviewed the literature on previous intravitreal injections as a risk factor of PCR and performed meta-analyses to provide pooled summary risk estimates. Methods: We searched 13 literature databases on 1 June 2021 for studies evaluating the risk of PCR in eyes undergoing cataract surgery with data on previous intravitreal injections. Data extraction was made independently by two authors and discussed afterwards until reaching consensus. Random effects meta-analyses on the pooled odds ratio (OR) of PCR in eyes with previous intravitreal injections were made using MetaXL 5.3. Results: Six studies on 1 051 097 eyes undergoing cataract surgery were eligible for the qualitative and quantitative review. Previous history of intravitreal injections was present in 7034 eyes (majority was anti-VEGF). Our meta-analyses revealed that any previous intravitreal injection was a risk factor for PCR with an OR of 2.30 (95% CI 1.39–3.81). For each previous intravitreal injection, the risk of PCR was OR 1.04 (95% CI 1.01–1.08) (equivalent of relative risk ~1.04). In other words, risk of PCR increases by 4% for each previous intravitreal injection. Conclusions: Previous intravitreal injection is a risk factor for PCR and should be taken into account when planning cataract surgery. However, to be regarded as a clinically significant risk of PCR, a substantial number of previous intravitreal injection (e.g. ≥10) should have been administered, considering that the a priori risk of PCR is very low (~1%).",
author = "Jakob Bjerager and {van Dijk}, {Elon H.C.} and Holm, {Lars Morten} and Amardeep Singh and Yousif Subhi",
note = "Publisher Copyright: {\textcopyright} 2022 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd",
year = "2022",
doi = "10.1111/aos.15089",
language = "English",
volume = "100",
pages = " 614--623",
journal = "Acta Ophthalmologica",
issn = "1755-375X",
publisher = "Wiley-Blackwell",
number = "6",

}

RIS

TY - JOUR

T1 - Previous intravitreal injection as a risk factor of posterior capsule rupture in cataract surgery

T2 - a systematic review and meta-analysis

AU - Bjerager, Jakob

AU - van Dijk, Elon H.C.

AU - Holm, Lars Morten

AU - Singh, Amardeep

AU - Subhi, Yousif

N1 - Publisher Copyright: © 2022 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd

PY - 2022

Y1 - 2022

N2 - Purpose: Intravitreal injections and cataract surgery are two common procedures in the elderly. Posterior capsular rupture (PCR) is a rare but important complication of cataract surgery. We systematically reviewed the literature on previous intravitreal injections as a risk factor of PCR and performed meta-analyses to provide pooled summary risk estimates. Methods: We searched 13 literature databases on 1 June 2021 for studies evaluating the risk of PCR in eyes undergoing cataract surgery with data on previous intravitreal injections. Data extraction was made independently by two authors and discussed afterwards until reaching consensus. Random effects meta-analyses on the pooled odds ratio (OR) of PCR in eyes with previous intravitreal injections were made using MetaXL 5.3. Results: Six studies on 1 051 097 eyes undergoing cataract surgery were eligible for the qualitative and quantitative review. Previous history of intravitreal injections was present in 7034 eyes (majority was anti-VEGF). Our meta-analyses revealed that any previous intravitreal injection was a risk factor for PCR with an OR of 2.30 (95% CI 1.39–3.81). For each previous intravitreal injection, the risk of PCR was OR 1.04 (95% CI 1.01–1.08) (equivalent of relative risk ~1.04). In other words, risk of PCR increases by 4% for each previous intravitreal injection. Conclusions: Previous intravitreal injection is a risk factor for PCR and should be taken into account when planning cataract surgery. However, to be regarded as a clinically significant risk of PCR, a substantial number of previous intravitreal injection (e.g. ≥10) should have been administered, considering that the a priori risk of PCR is very low (~1%).

AB - Purpose: Intravitreal injections and cataract surgery are two common procedures in the elderly. Posterior capsular rupture (PCR) is a rare but important complication of cataract surgery. We systematically reviewed the literature on previous intravitreal injections as a risk factor of PCR and performed meta-analyses to provide pooled summary risk estimates. Methods: We searched 13 literature databases on 1 June 2021 for studies evaluating the risk of PCR in eyes undergoing cataract surgery with data on previous intravitreal injections. Data extraction was made independently by two authors and discussed afterwards until reaching consensus. Random effects meta-analyses on the pooled odds ratio (OR) of PCR in eyes with previous intravitreal injections were made using MetaXL 5.3. Results: Six studies on 1 051 097 eyes undergoing cataract surgery were eligible for the qualitative and quantitative review. Previous history of intravitreal injections was present in 7034 eyes (majority was anti-VEGF). Our meta-analyses revealed that any previous intravitreal injection was a risk factor for PCR with an OR of 2.30 (95% CI 1.39–3.81). For each previous intravitreal injection, the risk of PCR was OR 1.04 (95% CI 1.01–1.08) (equivalent of relative risk ~1.04). In other words, risk of PCR increases by 4% for each previous intravitreal injection. Conclusions: Previous intravitreal injection is a risk factor for PCR and should be taken into account when planning cataract surgery. However, to be regarded as a clinically significant risk of PCR, a substantial number of previous intravitreal injection (e.g. ≥10) should have been administered, considering that the a priori risk of PCR is very low (~1%).

U2 - 10.1111/aos.15089

DO - 10.1111/aos.15089

M3 - Review

C2 - 35060678

AN - SCOPUS:85123266138

VL - 100

SP - 614

EP - 623

JO - Acta Ophthalmologica

JF - Acta Ophthalmologica

SN - 1755-375X

IS - 6

ER -

ID: 291359331